Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > What are the odds?
View:
Post by riverrrow on Jun 10, 2024 3:50pm

What are the odds?

The odds of three major scientific breakthroughs occurring within one week seem rather remote.  Management has to have been sitting on one or two of them.  Combine them with the fact that management did not participate in the last private placement ( another rarity in itself) and could these events portend a major funding announcement such as a jv?  GLTA.
Comment by plantrader on Jun 10, 2024 3:53pm
Same thoughts here re: it makes sense that they had to have been sitting on these announcements to cluster them together as a primer for funding purposes or whatever else.
Comment by Gooseybear on Jun 10, 2024 4:45pm
Either this is the most underrated stock in history or one of the biggest scams. I'm betting on underrated since the regulators have already been keeping a keen eye on any corporate communications accuracy since Roger's return I believe.
Comment by plantrader on Jun 10, 2024 4:56pm
Goosey, You might have just made a key point. I'm sure they know they likely can't afford to be sanctioned again. Maybe it's just the pervasive concern about this exchange and its inhabitants being unpredictable, lots of scams and misdirection. And they're lumping TLT in with all of the garbage until definitively proven otherwise. Such as BTD or a JV, etc.
Comment by Alamir1111 on Jun 10, 2024 5:19pm
Otc market is that German  exchange? 
Comment by menoalittle on Jun 10, 2024 5:21pm
The market in general probably won't even start to "discover" this stock until the day it trades over 20 million shares and hits a solid double.  After that, maybe FOMO starts to kick in, and the rocket launch is underway. Until then, it is mostly but a handful... well, better make that a roomful... of longtime/longsuffering (and very patience) venture capitalists that have ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250